Therefore, following validation of pSer-324 antibody specificity (supplemental Fig. S3), we assessed whether pSer-324–positive tau species were detected along with other phospho-tau epitopes in our recently developed AAV model of tauopathy (13). The gene discussed is MAPT; the disease is tauopathy.